Humacyte (HUMA) Inventory (2025 - 2026)
Humacyte (HUMA) reported Inventory of $20.4 million for Q1 2026, up 155.0% year-over-year from $8.0 million in Q1 2025, and down 9.33% quarter-over-quarter from $22.5 million in Q4 2025.
Humacyte (HUMA) Inventory (2025 - 2026) Analysis & Trends
Humacyte (HUMA) has 2 years of Inventory data on file, last reported at $20.4 million in Q1 2026.
- Inventory for Q1 2026 came in at $20.4 million, up 155.0% year-over-year; the trailing twelve-month figure through Mar 2026 was $20.4 million (up 155.0% YoY), and the FY2025 annual result was $22.5 million, changed N/A from the prior year.
- Inventory declined to $20.4 million in Q1 2026 per HUMA's latest filing, from $22.5 million in the prior quarter.
- Over five years, Inventory peaked at $22.5 million in Q4 2025 and troughed at $8.0 million in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | - |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | 32.00 Mn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | - |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | 1.77 Bn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | - |
| 10 | Humacyte | 267.09 Mn | 218.55 Mn | -1.54 Mn | 20.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 20.40 Mn |
| Dec 31, 2025 | 22.50 Mn |
| Sep 30, 2025 | 18.40 Mn |
| Jun 30, 2025 | 11.10 Mn |
| Mar 31, 2025 | 8.00 Mn |